Evidence map›Paper›PMID 27557953›Full record

ArticleParticle and fibre toxicology2016

Quantification of the cellular dose and characterization of nanoparticle transport during in vitro testing.

Grigore Rischitor, Mariantonietta Parracino, Rita La Spina, Patricia Urbán, Isaac Ojea-Jiménez, Elena Bellido, Andrea Valsesia, Sabrina Gioria, Robin Capomaccio, Agnieszka Kinsner-Ovaskainen and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Particle and fibre toxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The virtual cell based assay: Current status and future perspectives.Toxicology in vitro : an international journal published in association with BIBRA · 2017
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Grigore RischitorEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Mariantonietta ParracinoPresent address : Nanoimmunotech S.L., Av. de la Autonomía, 50003, Zaragoza, Spain.
Rita La SpinaEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Patricia UrbánEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Isaac Ojea-JiménezEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Elena BellidoEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Andrea ValsesiaEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Sabrina GioriaEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Robin CapomaccioEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Agnieszka Kinsner-OvaskainenEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Douglas GillilandEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
François RossiEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy.
Pascal ColpoEuropean Commission Joint Research Centre, Institute for Health and Consumer and Protection, Nanobiosciences Unit, Via E. Fermi 2749, 21027, Ispra, VA, Italy. pascal.colpo@ec.europa.eu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe constant increase of the use of nanomaterials in consumer products is making increasingly urgent that standardized and reliable in vitro test methods for toxicity screening be made available to the scientific community. For this purpose, the determination of the cellular dose, i.e. the amount of nanomaterials effectively in contact with the cells is fundamental for a trustworthy determination of nanomaterial dose responses. This has often been overlooked in the literature making it difficult to undertake a comparison of datasets from different studies. Characterization of the mechanisms involved in nanomaterial transport and the determination of the cellular dose is essential for the development of predictive numerical models and reliable in vitro screening methods.

resultsThis work aims to relate key physico-chemical properties of gold nanoparticles (NPs) to the kinetics of their deposition on the cellular monolayer. Firstly, an extensive characterization of NPs in complete culture cell medium was performed to determine the diameter and the apparent mass density of the formed NP-serum protein complexes. Subsequently, the kinetics of deposition were studied by UV-vis absorbance measurements in the presence or absence of cells. The fraction of NPs deposited on the cellular layer was found to be highly dependent on NP size and apparent density because these two parameters influence the NP transport. The NP deposition occurred in two phases: phase 1, which consists of cellular uptake driven by the NP-cell affinity, and phase 2 consisting mainly of NP deposition onto the cellular membrane.

conclusionThe fraction of deposited NPs is very different from the initial concentration applied in the in vitro assay, and is highly dependent of the size and density of the NPs, on the associated transport rate and on the exposure duration. This study shows that an accurate characterization is needed and suitable experimental conditions such as initial concentration of NPs and liquid height in the wells has to be considered since they strongly influence the cellular dose and the nature of interactions of NPs with the cells.

Indexed as

Dose-Response Relationship, DrugHumansIn Vitro TechniquesNanoparticlesSpectrophotometry, UltravioletCell uptakeColloidal stabilityDosimetryIn vitro assayNanoparticle characterizationNanoparticlesNanoparticle transport

Identifiers

PMID27557953
PMCPMC4995798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.